Its role in the synthesis is to provide the N-(2,6-dimethylphenyl)glycinate backbone of the molecule, which is later modified and incorporated into the final structure, typically through an acylation step or as a component in a Ugi four-component reaction (Ugi-4CR). Ethyl (2,6-dimethylphenyl)glycinate is a key intermediate in the synthesis of Amenamevir (also known as ASP2151), a potent helicase-primase inhibitor used to treat herpes zoster.
Ethyl (2,6-dimethylphenyl)glycinate
| API Name | Amenamevir |
|---|---|
| CAS No | 2371-25-7 |
| Molecular Formula | C12H17NO2 |
| Molecular Weight | 207.27 g/mol |
| Synonyms | ethyl 2-(2,6-dimethylanilino)acetate |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
Its role in the synthesis is to provide the N-(2,6-dimethylphenyl)glycinate backbone of the molecule, which is later modified and incorporated into the final structure, typically through an acylation step or as a component in a Ugi four-component reaction (Ugi-4CR). Ethyl (2,6-dimethylphenyl)glycinate is a key intermediate in the synthesis of Amenamevir (also known as ASP2151), a potent helicase-primase inhibitor used to treat herpes zoster.
The CAS number of Ethyl (2,6-dimethylphenyl)glycinate is 2371-25-7.
The molecular formula of Ethyl (2,6-dimethylphenyl)glycinate is C12H17NO2.
The listed molecular weight of Ethyl (2,6-dimethylphenyl)glycinate is 207.27 g/mol.
Ethyl (2,6-dimethylphenyl)glycinate is listed as being used in connection with the following API: Amenamevir.
The listed synonym or IUPAC name for Ethyl (2,6-dimethylphenyl)glycinate is ethyl 2-(2,6-dimethylanilino)acetate.